Paloma Partners Management CO Incyte Corp Call Options Transaction History

Paloma Partners Management CO

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $633,880 - $785,304	10,400 New	10,400 $647,000
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $44,112 - $53,220	600 Added 14.63%	4,700 $399,000
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $260,596 - $361,497	4,100 New	4,100 $353,000
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $1.62 Million - $1.97 Million	-19,500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $785,904 - $979,440	8,400 Added 75.68%	19,500 $1.85 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $1.21 Million - $1.53 Million	11,100	11,100 $1.3 Million

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.